Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.35B | 4.93B | 4.93B | 4.92B | 4.93B | 3.68B | Gross Profit |
2.25B | 2.18B | 2.13B | 2.05B | 2.16B | 1.64B | EBIT |
515.90M | 634.20M | 607.20M | 680.60M | 912.30M | 532.10M | EBITDA |
702.90M | 804.20M | 739.30M | 807.30M | 1.00B | 627.40M | Net Income Common Stockholders |
274.90M | 384.30M | 368.10M | 455.70M | 624.50M | 348.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
111.10M | 117.40M | 74.90M | 69.40M | 300.70M | 65.00M | Total Assets |
11.33B | 5.98B | 4.55B | 4.36B | 4.32B | 3.31B | Total Debt |
2.02B | 4.47B | 3.27B | 3.37B | 2.86B | 1.70B | Net Debt |
1.91B | 4.35B | 3.19B | 3.30B | 2.56B | 1.64B | Total Liabilities |
8.58B | 5.41B | 4.22B | 4.37B | 4.03B | 2.80B | Stockholders Equity |
2.74B | 559.00M | 323.40M | -22.10M | 285.80M | 503.60M |
Cash Flow | Free Cash Flow | ||||
552.90M | 569.20M | 384.90M | 72.30M | 599.80M | 543.40M | Operating Cash Flow |
642.70M | 666.50M | 570.30M | 378.80M | 723.10M | 654.70M | Investing Cash Flow |
-2.92B | -96.70M | -187.80M | -315.30M | -554.80M | -146.60M | Financing Cash Flow |
2.30B | 1.08B | -384.30M | -279.10M | 76.50M | -522.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $4.43B | 26.81 | 22.16% | 2.21% | 10.32% | 18.55% | |
77 Outperform | $12.61B | 81.99 | 36.79% | ― | 85.99% | ― | |
77 Outperform | $13.65B | 42.01 | 17.92% | 0.85% | 8.96% | -22.99% | |
67 Neutral | $6.63B | 61.27 | 15.97% | ― | 46.27% | -26.45% | |
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
59 Neutral | $4.38B | 40.12 | -10.58% | ― | -1.68% | -302.11% | |
59 Neutral | $24.63B | 147.29 | -17.27% | 2.50% | -3.70% | -235.59% |
On May 14, 2025, Somnigroup International held its Annual Meeting of Stockholders where 168,959,709 shares were represented out of the 208,582,329 outstanding shares. During the meeting, all company nominees for director positions were elected, Ernst and Young LLP was ratified as the independent auditor for the year ending December 31, 2025, and the compensation of the company’s named executive officers was approved on an advisory basis.
The most recent analyst rating on (SGI) stock is a Buy with a $61.00 price target. To see the full list of analyst forecasts on Somnigroup International stock, see the SGI Stock Forecast page.
On May 12, 2025, Somnigroup International Inc. announced a secondary offering of 15,376,743 shares of its common stock by the former majority shareholder of Mattress Firm Group Inc., a subsidiary of IBEX Topco B.V. The shares were sold to Goldman Sachs & Co. LLC, acting as the sole underwriter, and Somnigroup will not receive any proceeds from this transaction. The offering was registered under the Securities Act of 1933, and the shares were sold on May 13, 2025. This transaction does not involve Somnigroup issuing or selling any new shares, and it is part of a broader strategy to manage shareholder interests and market positioning.
The most recent analyst rating on (SGI) stock is a Buy with a $61.00 price target. To see the full list of analyst forecasts on Somnigroup International stock, see the SGI Stock Forecast page.
On May 8, 2025, Somnigroup International Inc. released an updated investor presentation to be used in meetings with investors. The presentation highlights the company’s strategic direction, focusing on consumer-centric innovation and operational excellence. Somnigroup’s vertically integrated strategy and robust capital allocation are designed to optimize consumer experience and drive sales growth. The company anticipates tariff impacts in 2025, with potential price increases to be passed to consumers. Since 2015, Somnigroup has seen significant growth in sales, EBITDA, and EPS, reflecting its strong market positioning and effective management.